Martin Eilers

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma”.

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

Journal of Clinical Investigation(2020)10.1172/jci134132

N/A

0DataRank · unranked

71 citations

Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert +38 more

Protein phosphatases in the RNAPII transcription cycle: erasers, sculptors, gatekeepers, and potential drug targets

Genes & Development(2021)10.1101/gad.348315.121

N/A

0DataRank · unranked

72 citations

Pabitra K. Parua, Martin Eilers, Robert P. Fisher, Giacomo Cossa

MYC determines lineage commitment in KRAS-driven primary liver cancer development

Journal of Hepatology(2023)10.1016/j.jhep.2023.02.039

N/A

0DataRank · unranked

38 citations

Athina Anastasia Moschopoulou, Iros Barozzi, Amanda J. Craig, Marco Seehawer, Lea Herrmann +15 more

eLife Assessment: Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

(2023)10.7554/elife.90683.1.sa2

N/A

0DataRank · unranked

0 citations

Martin Eilers

Tafazzin-Mediated Cardiolipin Remodeling Controls Metabolic Stress Response and Effector Function of Inflammatory T Cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.25.672061

N/A

0DataRank · unranked

0 citations

Sophia Hochrein, Miriam Eckstein, Hao Wu, Katrin Sinning, Katharina J. Ermer +9 more